Japan Proton Therapy Market, Share, Forecast 2024-2030, Industry Trends, Growth, Size, Companies Analysis

1.    Introduction

2.    Research & Methodology
3.    Executive Summary

4.    Market Dynamics

4.1    Growth Drivers
4.2    Challenges

5.    Japan Proton Therapy Market (Actual & Untapped)

5.1    Actual Proton Therapy Market
5.2    Untapped Proton Therapy Market

6.    Number of Patients – Japan Proton Therapy

6.1    Actual Numbers
6.2    Untapped Numbers

7.    Cancer Types – Japan Proton Therapy Number of Patients

7.1    Central Nervous System (CNS) Tumors
7.2    Head and Neck Cancer
7.3    Lung Cancer
7.4    GI (Gastro-Intestinal) Cancer
7.5    Hepatocellular Carcinoma (HCC) Cancer
7.6    Pancreas Cancer
7.7    Gynecologic Cancers
7.8    Prostate Cancer
7.9    Bone and Soft Tissue Cancer
7.10    Others Cancer

8.    Cancer Types – Japan Proton Therapy Market

8.1    Central Nervous System (CNS) Tumors
8.2    Head and Neck Cancer
8.3    Lung Cancer
8.4    GI (Gastro-Intestinal) Cancer
8.5    Hepatocellular Carcinoma (HCC) Cancer
8.6    Pancreas Cancer
8.7    Gynecologic Cancers
8.8    Prostate Cancer
8.9    Bone and Soft Tissue Cancer
8.10    Others Cancer

9.    Japan – List of Proton Therapy Centers

9.1    Operating Proton Therapy Centers
9.2    Under-Construction Therapy Centers

10.    Reimbursement Policies – Japan Proton Therapy

11.    Components of a Standard Proton Therapy Center

11.1    Type of Proton Accelerator

11.1.1    Synchrotrons (example: LLUMC at Loma Linda)
11.1.2    Cyclotrons (example: MGH Boston)
11.1.3    Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4    Linacs (Rome)
11.1.5    H-minus Synchrotrons
11.1.6    Separated Sector Cyclotrons
11.1.7    Super-conducting Cyclotrons
11.1.8    Fast Cycling Synchrotron

11.2    Beam Transport System

11.3    Beam Delivery System

11.3.1    The Passive Scattering Technique
11.3.2    Beam Scanning

11.4    Type of Nozzle

11.4.1    Single Scattering
11.4.2    Double Scattering
11.4.3    Uniform Scanning Nozzle
11.4.4    Pencil Scanning Nozzle

11.5    Treatment Planning System
11.6    Image Viewers
11.7    Patient Positioning System (PPS)
11.8    Human Resource

12.    Porters Five Forces

12.1    Overview
12.2    Bargaining Power of Buyers
12.3    Bargaining Power of Suppliers
12.4    Degree of Competition
12.5    Threat of New Entrants
12.6    Threat of Substitutes

13.    Company Analysis

13.1    IBA Proton Therapy

13.1.1    Overview
13.1.2    Recent Development
13.1.3    Sales Analysis

13.2    Varian Medical Systems

13.2.1    Overview
13.2.2    Recent Development
13.2.3    Sales Analysis

13.3    Elekta

13.3.1    Overview
13.3.2    Recent Development
13.3.3    Sales Analysis

List Of Figures:

Figure-01:        Japan – Actual Proton Therapy Market (Million US$), 2016 – 2021
Figure-02:        Japan – Forecast for Actual Proton Therapy Market (Million US$), 2022 – 2027
Figure-03:        Japan – Untapped Proton Therapy Market (Million US$), 2016 – 2021
Figure-04:        Japan – Forecast for Untapped Proton Therapy Market (Million US$), 2022 – 2027
Figure-05:        Japan – Actual Numbers (Number), 2016 – 2021
Figure-06:        Japan – Forecast for Actual Numbers (Number), 2022 – 2027
Figure-07:        Japan – Untapped Numbers (Number), 2016 – 2021
Figure-08:        Japan – Forecast for Untapped Numbers (Number), 2022 – 2027
Figure-09:        Japan – Central Nervous System (CNS) Tumors Patients (Number), 2016 – 2021
Figure-10:        Japan – Forecast for Central Nervous System (CNS) Tumors Patients (Number), 2022 – 2027
Figure-11:        Japan – Head and Neck Cancer Patients (Number), 2016 – 2021
Figure-12:        Japan – Forecast for Head and Neck Cancer Patients (Number), 2022 – 2027
Figure-13:        Japan – Lung Cancer Patients (Number), 2016 – 2021
Figure-14:        Japan – Forecast for Lung Cancer Patients (Number), 2022 – 2027
Figure-15:        Japan – GI (Gastro-Intestinal) Cancer Patients (Number), 2016 – 2021
Figure-16:        Japan – Forecast for GI (Gastro-Intestinal) Cancer Patients (Number), 2022 – 2027
Figure-17:        Japan – Hepatocellular Carcinoma (HCC) Cancer Patients (Number), 2016 – 2021
Figure-18:        Japan – Forecast for Hepatocellular Carcinoma (HCC) Cancer Patients (Number), 2022 – 2027
Figure-19:        Japan – Pancreas Cancer Patients (Number), 2016 – 2021
Figure-20:        Japan – Forecast for Pancreas Cancer Patients (Number), 2022 – 2027
Figure-21:        Japan – Gynecologic Cancers Patients (Number), 2016 – 2021
Figure-22:        Japan – Forecast for Gynecologic Cancers Patients (Number), 2022 – 2027
Figure-23:        Japan – Prostate Cancer Patients (Number), 2016 – 2021
Figure-24:        Japan – Forecast for Prostate Cancer Patients (Number), 2022 – 2027
Figure-25:        Japan – Bone and Soft Tissue Cancer Patients (Number), 2016 – 2021
Figure-26:        Japan – Forecast for Bone and Soft Tissue Cancer Patients (Number), 2022 – 2027
Figure-27:        Japan – Others Cancer Patients (Number), 2016 – 2021
Figure-28:        Japan – Forecast for Others Cancer Patients (Number), 2022 – 2027
Figure-29:        Japan – Central Nervous System (CNS) Tumors Market (Million US$), 2016 – 2021
Figure-30:        Japan – Forecast for Central Nervous System (CNS) Tumors Market (Million US$), 2022 – 2027
Figure-31:        Japan – Head and Neck Cancer Market (Million US$), 2016 – 2021
Figure-32:        Japan – Forecast for Head and Neck Cancer Market (Million US$), 2022 – 2027
Figure-33:        Japan – Lung Cancer Market (Million US$), 2016 – 2021
Figure-34:        Japan – Forecast for Lung Cancer Market (Million US$), 2022 – 2027
Figure-35:        Japan – GI (Gastro-Intestinal) Cancer Market (Million US$), 2016 – 2021
Figure-36:        Japan – Forecast for GI (Gastro-Intestinal) Cancer Market (Million US$), 2022 – 2027
Figure-37:        Japan – Hepatocellular Carcinoma (HCC) Cancer Market (Million US$), 2016 – 2021
Figure-38:        Japan – Forecast for Hepatocellular Carcinoma (HCC) Cancer Market (Million US$), 2022 – 2027
Figure-39:        Japan – Pancreas Cancer Market (Million US$), 2016 – 2021
Figure-40:        Japan – Forecast for Pancreas Cancer Market (Million US$), 2022 – 2027
Figure-41:        Japan – Gynecologic Cancers Market (Million US$), 2016 – 2021
Figure-42:        Japan – Forecast for Gynecologic Cancers Market (Million US$), 2022 – 2027
Figure-43:        Japan – Prostate Cancer Market (Million US$), 2016 – 2021
Figure-44:        Japan – Forecast for Prostate Cancer Market (Million US$), 2022 – 2027
Figure-45:        Japan – Bone and Soft Tissue Cancer Market (Million US$), 2016 – 2021
Figure-46:        Japan – Forecast for Bone and Soft Tissue Cancer Market (Million US$), 2022 – 2027
Figure-47:        Japan – Others Cancer Market (Million US$), 2016 – 2021
Figure-48:        Japan – Forecast for Others Cancer Market (Million US$), 2022 – 2027
Figure-49:        IBA Proton Therapy – Global Revenue (Million US$), 2016 – 2021
Figure-50:        IBA Proton Therapy – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51:        Varian Medical Systems – Global Revenue (Million US$), 2016 – 2021
Figure-52:        Varian Medical Systems – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53:        Elekta – Global Revenue (Million US$), 2016 – 2021
Figure-54:        Elekta – Forecast for Global Revenue (Million US$), 2022 – 2027

List Of Tables:

Table-1:        Japan – Proton Therapy Centers in Operation
Table-2:        Japan – Proton Therapy Centers in Under-Construction